User talk:Neelakshi.E.Bhagatne
From EyeWiki
Assigned editor status
| Article status | Date reviewed | |
|---|---|---|
| Acquired Retinal Macroaneurysm | Up to Date | 6 February 2026 |
| Acute Macular Neuroretinopathy | Update Pending | 19 September 2025 |
| Artificial Intelligence in Ophthalmology | Update Pending | 20 October 2024 |
| Basal Laminar Drusen | Up to Date | 13 March 2026 |
| Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) | Update Pending | 19 September 2025 |
| Brolucizumab | Up to Date | 13 March 2026 |
| CMV Retinitis | Up to Date | 15 February 2026 |
| Central Areolar Choroidal Dystrophy | Up to Date | 15 February 2026 |
| Choroidal Folds | Update Pending | 19 September 2025 |
| Commotio Retinae | Update Pending | 19 September 2025 |
| Diabetic Macular Edema | Up to Date | 13 March 2026 |
| Epiretinal Membrane | Update Pending | 19 September 2025 |
| Familial Retinal Arterial Macroaneurysms (FRAM) | Up to Date | 15 February 2026 |
| Fundus Autofluorescence | Update Pending | 19 September 2025 |
| Fungal Endophthalmitis | Up to Date | 15 February 2026 |
| Giant Retinal Tears | Up to Date | 6 February 2026 |
| Horseshoe or Flap Tear | Up to Date | 15 February 2026 |
| Hyperbaric Oxygen Therapy | Update Pending | 19 September 2025 |
| Hypertensive Retinopathy | Update Pending | 19 September 2025 |
| Kyrieleis Plaques | Up to Date | 6 February 2026 |
| Lymphocytic Choriomeningitis Virus | Update Pending | 19 September 2025 |
| Macroaneurysm | Update Pending | 19 September 2025 |
| Mittendorf Dot | Update Pending | 19 September 2025 |
| Multiple Evanescent White Dot Syndrome | Up to Date | 15 February 2026 |
| Ocular Candidiasis | Update Pending | 19 September 2025 |
| ... further results | ||
- Retina/Vitreous (Main editor: Leo.A.Kim, Editor: Sun.Y.Lee, Koushik.Tripathy, Jason.Hsu, Neelakshi.E.Bhagatne, Vamsi.Gullapalli, Nimesh.Patel, RazekGeorges.Coussa, Durga.Borkar, Vaidehi.Dedania, Brittni.Scruggs, Amir.Hajrasouliha, Mark.Breazzano, Avni.Finn, Michael.Javaheri, Ines.Lains, Brian.K.Do.CMT)
